Search

Author/Creator Im, Young-Hyuck

1. 5-year analysis of neoadjuvant pertuzumab and trastuzumab in patients with locally advanced, inflammatory, or early-stage HER2-positive breast cancer (NeoSphere): a multicentre, open-label, phase 2 randomised trial. Issue 6 (June 2016)

Authors:
Gianni, Luca; Pienkowski, Tadeusz; Im, Young-Hyuck; Tseng, Ling-Ming; Liu, Mei-Ching; Lluch, Ana; Starosławska, Elżbieta; de la Haba-Rodriguez, Juan; Im, Seock-Ah; Pedrini, Jose Luiz; Poirier, Brigitte; Morandi, Paolo; Semiglazov, Vladimir; Srimuninnimit, Vichien; Bianchi, Giulia Valeria; Magazzù...
Journal:
Lancet oncology
Issue:
Volume 17:Issue 6(2016:Jun.)
Page Start:
791
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer in the APHINITY Trial: 6 Years' Follow-Up. Issue 13 (1st May 2021)

Authors:
Piccart, Martine; Procter, Marion; Fumagalli, Debora; de Azambuja, Evandro; Clark, Emma; Ewer, Michael S.; Restuccia, Eleonora; Jerusalem, Guy; Dent, Susan; Reaby, Linda; Bonnefoi, Hervé; Krop, Ian; Liu, Tsang-Wu; Pieńkowski, Tadeusz; Toi, Masakazu; Wilcken, Nicholas; Andersson, Michael; Im, Youn...
Journal:
Journal of clinical oncology
Issue:
Volume 39:Issue 13(2021)
Page Start:
1448
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Afatinib plus vinorelbine versus trastuzumab plus vinorelbine in patients with HER2-overexpressing metastatic breast cancer who had progressed on one previous trastuzumab treatment (LUX-Breast 1): an open-label, randomised, phase 3 trial. Issue 3 (March 2016)

Authors:
Harbeck, Nadia; Huang, Chiun-Sheng; Hurvitz, Sara; Yeh, Dah-Cherng; Shao, Zhimin; Im, Seock-Ah; Jung, Kyung Hae; Shen, Kunwei; Ro, Jungsil; Jassem, Jacek; Zhang, Qingyuan; Im, Young-Hyuck; Wojtukiewicz, Marek; Sun, Qiang; Chen, Shin-Cheh; Goeldner, Rainer-Georg; Uttenreuther-Fischer, Martina; Xu,...
Journal:
Lancet oncology
Issue:
Volume 17:Issue 3(2016:Mar.)
Page Start:
357
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Biomarker analysis of the NeoSphere study: pertuzumab, trastuzumab, and docetaxel versus trastuzumab plus docetaxel, pertuzumab plus trastuzumab, or pertuzumab plus docetaxel for the neoadjuvant treatment of HER2-positive breast cancer. Issue 1 (December 2017)

Authors:
Bianchini, Giampaolo; Kiermaier, Astrid; Bianchi, Giulia; Im, Young-Hyuck; Pienkowski, Tadeusz; Liu, Mei-Ching; Tseng, Ling-Ming; Dowsett, Mitch; Zabaglo, Lila; Kirk, Sarah; Szado, Tania; Eng-Wong, Jennifer; Amler, Lukas; Valagussa, Pinuccia; Gianni, Luca
Journal:
Breast cancer research
Issue:
Volume 19:Issue 1(2017)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Clinical implication of tumor mutational burden in patients with HER2-positive refractory metastatic breast cancer. (3rd August 2018)

Authors:
Park, Song Ee; Park, Kyunghee; Lee, Eunjin; Kim, Ji-Yeon; Ahn, Jin Seok; Im, Young-Hyuck; Lee, Choonghoon; Jung, Hun; Cho, Soo Youn; Park, Woong-Yang; Cristescu, Razvan; Park, Yeon Hee
Journal:
Oncoimmunology
Issue:
Volume 7:Number 8(2018)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Correlation between work productivity loss and EORTC QLQ-C30 and -BR23 domains from the MONALEESA-7 trial of premenopausal women with HR+/HER2− advanced breast cancer. (February 2022)

Authors:
Tripathy, Debu; Curteis, Tristan; Hurvitz, Sara; Yardley, Denise; Franke, Fabio; Babu, K. Govind; Wheatley-Price, Paul; Im, Young-Hyuck; Pencheva, Radost; Eddowes, Lucy A.; Dionne, Pierre-Alexandre; Chandiwana, David; Pathak, Purnima; Lanoue, Brad; Harbeck, Nadia
Journal:
Therapeutic advances in medical oncology
Issue:
Volume 14(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Distress and body image due to altered appearance in posttreatment and active treatment of breast cancer patients and in general population controls. Issue 2 (6th March 2017)

Authors:
Kang, Danbee; Choi, Eun-Kyung; Kim, Im-Ryung; Nam, Seok Jin; Lee, Jeong Eon; Im, Young-Hyuck; Ahn, Jin Seok; Park, Yeon Hee; Cho, Juhee
Journal:
Palliative & supportive care
Issue:
Volume 16:Issue 2(2018)
Page Start:
137
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Fulvestrant plus goserelin versus anastrozole plus goserelin versus goserelin alone for hormone receptor-positive, HER2-negative tamoxifen-pretreated premenopausal women with recurrent or metastatic breast cancer (KCSG BR10-04): a multicentre, open-label, three-arm, randomised phase II trial (FLAG study). (November 2018)

Authors:
Kim, Ji-Yeon; Im, Seock-Ah; Jung, Kyung Hae; Ro, Jungsil; Sohn, Joohyuk; Kim, Jee Hyun; Park, Yeon Hee; Kim, Tae-Yong; Kim, Sung-Bae; Lee, Keun Seok; Kim, Gun Min; Kim, Se Hyun; Kim, Seonwoo; Ahn, Jin Seok; Lee, Kyung-Hun; Ahn, Jin-Hee; Park, In Hae; Im, Young-Hyuck
Journal:
European journal of cancer
Issue:
Volume 103(2018)
Page Start:
127
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Health-related quality of life in premenopausal women with hormone-receptor-positive, HER2-negative advanced breast cancer treated with ribociclib plus endocrine therapy: results from a phase III randomized clinical trial (MONALEESA-7). (July 2020)

Authors:
Harbeck, Nadia; Franke, Fabio; Villanueva-Vazquez, Rafael; Lu, Yen-Shen; Tripathy, Debu; Chow, Louis; Babu, Govind K; Im, Young-Hyuck; Chandiwana, David; Gaur, Anil; Lanoue, Brad; Rodriguez-Lorenc, Karen; Bardia, Aditya
Journal:
Therapeutic advances in medical oncology
Issue:
Volume 12(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗